ED SILVERMAN:

Well, it all sounds wonderful, but the money has to be appropriated.

So, from day one, we have that question hanging over the entire effort. Will that money actually go as intended to the right agencies, so it can do the work? Presumably, the FDA will get funds, so they can have more resources to take on things like different approval processes.

But the money's got to be there. So, if it's not appropriated, well, then where are we? The agency will end up having more work without the added resources. And I think that's one of the struggles that has made the process over the past few weeks and months difficult to sort out and really feel comfortable that Congress is going to do what it says it will do.